• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膜型基质金属蛋白酶作为癌症进展的多种效应因子。

Membrane-type matrix metalloproteases as diverse effectors of cancer progression.

机构信息

Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Nobels väg 16, SE-17177 Stockholm, Sweden.

Research Programs Unit, Genome-Scale Biology and Haartman Institute, University of Helsinki, and Helsinki University Hospital, P.O. Box 63, FI-00014 Helsinki, Finland.

出版信息

Biochim Biophys Acta Mol Cell Res. 2017 Nov;1864(11 Pt A):1974-1988. doi: 10.1016/j.bbamcr.2017.04.002. Epub 2017 Apr 5.

DOI:10.1016/j.bbamcr.2017.04.002
PMID:28390905
Abstract

Membrane-type matrix metalloproteases (MT-MMP) are pivotal regulators of cell invasion, growth and survival. Tethered to the cell membranes by a transmembrane domain or GPI-anchor, the six MT-MMPs can exert these functions via cell surface-associated extracellular matrix degradation or proteolytic protein processing, including shedding or release of signaling receptors, adhesion molecules, growth factors and other pericellular proteins. By interactions with signaling scaffold or cytoskeleton, the C-terminal cytoplasmic tail of the transmembrane MT-MMPs further extends their functionality to signaling or structural relay. MT-MMPs are differentially expressed in cancer. The most extensively studied MMP14/MT1-MMP is induced in various cancers along malignant transformation via pathways activated by mutations in tumor suppressors or proto-oncogenes and changes in tumor microenvironment including cellular heterogeneity, extracellular matrix composition, tissue oxygenation, and inflammation. Classically such induction involves transcriptional programs related to epithelial-to-mesenchymal transition. Besides inhibition by endogenous tissue inhibitors, MT-MMP activities are spatially and timely regulated at multiple levels by microtubular vesicular trafficking, dimerization/oligomerization, other interactions and localization in the actin-based invadosomes, in both tumor and the stroma. The functions of MT-MMPs are multifaceted within reciprocal cellular responses in the evolving tumor microenvironment, which poses the importance of these proteases beyond the central function as matrix scissors, and necessitates us to rethink MT-MMPs as dynamic signaling proteases of cancer. This article is part of a Special Issue entitled: Matrix Metalloproteinases edited by Rafael Fridman.

摘要

膜型基质金属蛋白酶(MT-MMP)是细胞侵袭、生长和存活的关键调节因子。通过跨膜结构域或 GPI 锚定与细胞膜结合,这 6 种 MT-MMP 可以通过细胞表面相关的细胞外基质降解或蛋白水解加工来发挥这些功能,包括信号受体、黏附分子、生长因子和其他细胞周围蛋白的脱落或释放。通过与信号支架或细胞骨架相互作用,跨膜 MT-MMP 的 C 端胞质尾进一步扩展了其信号或结构传递功能。MT-MMP 在癌症中表达不同。研究最广泛的 MMP14/MT1-MMP 通过肿瘤抑制因子或原癌基因突变和肿瘤微环境变化(包括细胞异质性、细胞外基质组成、组织氧合和炎症)激活的途径,在各种癌症中沿恶性转化诱导表达。经典地,这种诱导涉及与上皮间质转化相关的转录程序。除了内源性组织抑制剂的抑制作用外,MT-MMP 活性还通过微管囊泡运输、二聚化/寡聚化、其他相互作用以及在肌动蛋白基侵袭小体中的定位,在肿瘤和基质中多个水平上进行时空调节。MT-MMP 的功能在不断演变的肿瘤微环境中的细胞相互反应中是多方面的,这使得这些蛋白酶的功能不仅仅局限于作为基质剪刀的核心功能,并且需要我们重新思考 MT-MMP 作为癌症的动态信号蛋白酶。本文是由 Rafael Fridman 编辑的特刊“基质金属蛋白酶”的一部分。

相似文献

1
Membrane-type matrix metalloproteases as diverse effectors of cancer progression.膜型基质金属蛋白酶作为癌症进展的多种效应因子。
Biochim Biophys Acta Mol Cell Res. 2017 Nov;1864(11 Pt A):1974-1988. doi: 10.1016/j.bbamcr.2017.04.002. Epub 2017 Apr 5.
2
Actin-associated protein palladin promotes tumor cell invasion by linking extracellular matrix degradation to cell cytoskeleton.肌动蛋白相关蛋白帕拉丁通过将细胞外基质降解与细胞细胞骨架相连来促进肿瘤细胞侵袭。
Mol Biol Cell. 2014 Sep 1;25(17):2556-70. doi: 10.1091/mbc.E13-11-0667. Epub 2014 Jul 2.
3
[The role of metalloproteinases in modification of extracellular matrix in invasive tumor growth, metastasis and angiogenesis].[金属蛋白酶在侵袭性肿瘤生长、转移和血管生成过程中对细胞外基质修饰的作用]
Postepy Hig Med Dosw (Online). 2012 Sep 10;66:609-28. doi: 10.5604/17322693.1009705.
4
Next generation matrix metalloproteinase inhibitors - Novel strategies bring new prospects.下一代基质金属蛋白酶抑制剂——新策略带来新前景。
Biochim Biophys Acta Mol Cell Res. 2017 Nov;1864(11 Pt A):1927-1939. doi: 10.1016/j.bbamcr.2017.06.009. Epub 2017 Jun 19.
5
Tumor cell invasion of collagen matrices requires coordinate lipid agonist-induced G-protein and membrane-type matrix metalloproteinase-1-dependent signaling.肿瘤细胞对胶原基质的侵袭需要脂质激动剂诱导的G蛋白和膜型基质金属蛋白酶-1依赖性信号传导协同作用。
Mol Cancer. 2006 Dec 8;5:69. doi: 10.1186/1476-4598-5-69.
6
MT4-(MMP17) and MT6-MMP (MMP25), A unique set of membrane-anchored matrix metalloproteinases: properties and expression in cancer.MT4-(基质金属蛋白酶17)和MT6-基质金属蛋白酶(基质金属蛋白酶25):一组独特的膜锚定基质金属蛋白酶:特性及其在癌症中的表达
Cancer Metastasis Rev. 2008 Jun;27(2):289-302. doi: 10.1007/s10555-008-9129-8.
7
Therapeutic Potential of Matrix Metalloproteinase Inhibition in Breast Cancer.基质金属蛋白酶抑制在乳腺癌中的治疗潜力
J Cell Biochem. 2017 Nov;118(11):3531-3548. doi: 10.1002/jcb.26185. Epub 2017 Jul 17.
8
Metalloproteinases in extracellular vesicles.细胞外囊泡中的金属蛋白酶。
Biochim Biophys Acta Mol Cell Res. 2017 Nov;1864(11 Pt A):1989-2000. doi: 10.1016/j.bbamcr.2017.05.027. Epub 2017 Jun 1.
9
The membrane tethered matrix metalloproteinase MT1-MMP at the forefront of melanoma cell invasion and metastasis.膜锚定基质金属蛋白酶MT1-MMP在黑色素瘤细胞侵袭和转移中处于前沿地位。
Pharmacol Res. 2016 Sep;111:17-22. doi: 10.1016/j.phrs.2016.05.019. Epub 2016 May 21.
10
Peripheral membrane associations of matrix metalloproteinases.基质金属蛋白酶的外周膜关联。
Biochim Biophys Acta Mol Cell Res. 2017 Nov;1864(11 Pt A):1964-1973. doi: 10.1016/j.bbamcr.2017.04.013. Epub 2017 Apr 23.

引用本文的文献

1
Matrix Metalloproteinases in Glioma: Drivers of Invasion and Therapeutic Targets.胶质瘤中的基质金属蛋白酶:侵袭驱动因素与治疗靶点
BioTech (Basel). 2025 Apr 15;14(2):28. doi: 10.3390/biotech14020028.
2
Potential target within the tumor microenvironment - MT1-MMP.肿瘤微环境中的潜在靶点——基质金属蛋白酶1(MT1-MMP)
Front Immunol. 2025 Mar 24;16:1517519. doi: 10.3389/fimmu.2025.1517519. eCollection 2025.
3
SLC25A35 enhances fatty acid oxidation and mitochondrial biogenesis to promote the carcinogenesis and progression of hepatocellular carcinoma by upregulating PGC-1α.
溶质载体家族25成员35(SLC25A35)通过上调过氧化物酶体增殖物激活受体γ共激活因子1α(PGC-1α)增强脂肪酸氧化和线粒体生物合成,从而促进肝细胞癌的发生和进展。
Cell Commun Signal. 2025 Mar 10;23(1):130. doi: 10.1186/s12964-025-02109-y.
4
The Anti-Metastatic Potential of Aronia Leaf Extracts on Colon Cancer Cells.刺玫蔷薇叶提取物对结肠癌细胞的抗转移潜力
Nutrients. 2024 Nov 28;16(23):4110. doi: 10.3390/nu16234110.
5
Long-Circulating and Targeted Liposomes Co-loading Cisplatin and Mifamurtide: Formulation and Delivery in Osteosarcoma Cells.长循环靶向脂质体共载顺铂和米伐木肽:骨肉瘤细胞中的制剂与递送。
AAPS PharmSciTech. 2024 Nov 26;25(8):272. doi: 10.1208/s12249-024-02992-7.
6
Identification and validation of matrix metalloproteinase hub genes as potential biomarkers for Skin Cutaneous Melanoma.鉴定和验证基质金属蛋白酶枢纽基因作为皮肤黑色素瘤的潜在生物标志物
Front Oncol. 2024 Oct 18;14:1471267. doi: 10.3389/fonc.2024.1471267. eCollection 2024.
7
The mechanism of MMP14-positive tumor-associated fibroblast subsets in inhibiting PD-1 immunotherapy for esophageal cancer through exosomal tsRNA-10522.MMP14 阳性肿瘤相关成纤维细胞亚群通过外泌体 tsRNA-10522 抑制食管癌 PD-1 免疫治疗的机制。
Funct Integr Genomics. 2024 Oct 8;24(5):186. doi: 10.1007/s10142-024-01447-3.
8
MMP-14 Exhibits Greater Expression, Content and Activity Compared to MMP-15 in Human Renal Carcinoma.MMP-14 在人类肾细胞癌中的表达、含量和活性均高于 MMP-15。
Int J Mol Sci. 2024 Jul 25;25(15):8107. doi: 10.3390/ijms25158107.
9
Gastric cancer fibroblasts affect the effect of immunotherapy and patient prognosis by inducing micro-vascular production.胃癌成纤维细胞通过诱导微血管生成影响免疫治疗效果和患者预后。
Front Immunol. 2024 Jul 8;15:1375013. doi: 10.3389/fimmu.2024.1375013. eCollection 2024.
10
Analysis of Membrane Type-1 Matrix Metalloproteinase (MT1-MMP, MMP14) in Eutopic and Ectopic Endometrium and in Serum and Endocervical Mucus of Endometriosis.子宫内膜异位症在位及异位内膜、血清和宫颈黏液中膜型基质金属蛋白酶-1(MT1-MMP,MMP14)的分析
Biomedicines. 2023 Oct 9;11(10):2730. doi: 10.3390/biomedicines11102730.